İçeriğe geç
akaturk Akademik ölçüm
Giriş Kayıt

Akademisyen

AYŞEGÜL ATEŞ DEĞİRMENCİ

ARAŞTIRMA GÖREVLİSİ

EGE ÜNİVERSİTESİ ECZACILIK FAKÜLTESİ TEMEL ECZACILIK BİLİMLERİ BÖLÜMÜ

  • Ana Dal Sağlık Bilimleri Temel Alanı
  • Yan Dal Farmasotik Mikrobiyoloji

Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.

  • Makale 20
  • Proje 0
  • Kitap 1
  • Bildiri 10
  • Patent 0
  • Sanatsal 0
Scopus (SJR) Q1 3 Q2 3 Q3 4 Q4 1
WoS (JCR) Q1 3 Q2 0 Q3 4 Q4 3
TR Index 9 makale

Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.

Üst %1 makale 0
Üst %10 makale 4
Ort. yüzdelik 49.4%
Üst %1 payı 0.0%
Üst %10 payı 25.0%

Makaleler

YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.

Dizin filtreleri

Toplam 20 yayın

Scopus (SJR)
Q1 3 Q2 3 Q3 4 Q4 1
WoS (JCR)
Q1 3 Q2 0 Q3 4 Q4 3
TR Index
9 makale

Makale listesi

  1. 2026 Effects of empagliflozin and metformin on biofilm formation and pathogenicity factors of urinary Escherichia coli isolates Folia Microbiologica DOI 10.1007/s12223-026-01520-3 YÖKSİS SJR Q2 JCR Q3 OpenAlex üst %10 OpenAlex 95.5%
  2. 2026 Targeting biofilm-related genes in a clinical methicillin-resistant Staphylococcus aureus isolate using CRISPR-Cas9 gene editing Frontiers in Microbiology DOI 10.3389/fmicb.2026.1843899 YÖKSİS SJR Q1 JCR Q1 OpenAlex 57.4%
  3. 2026 Lipoplex as a useful tool for resensitization of methicillin-resistant Staphylococcus aureus to erythromycin via CRISPR-Cas technology International Journal of Pharmaceutics DOI 10.1016/j.ijpharm.2026.127105 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 92.4%
  4. 2026 Empagliflozin modulates biofilm formation and virulence-associated gene expression in multidrug-resistant Staphylococcus aureus and Acinetobacter baumannii Archives of Microbiology DOI 10.1007/s00203-026-04955-x YÖKSİS SJR Q2 JCR Q3 OpenAlex 49.0%
  5. 2024 Antibacterial activity and cytocompatibility evaluation of cefpodoxime proxetil loaded eudragit rs 100 nanoparticles Journal of Research in Pharmacy DOI 10.29228/jrp.706 YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 39.4%
  6. 2024 CRISPR-Cas9-Mediated Targeting of Multidrug Resistance Genes in Methicillin-Resistant Staphylococcus aureus The CRISPR Journal DOI 10.1089/crispr.2024.0001 YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 91.9%
  7. 2024 Precision Genome Editing Unveils a Breakthrough in Reversing Antibiotic Resistance: CRISPR/Cas9 Targeting of Multi-Drug Resistance Genes in Methicillin-ResistantStaphylococcus aureus biorxiv DOI 10.1101/2023.12.31.573511 YÖKSİS
  8. 2024 An innovative approach to biofilm-associated infections: CRISPR/Cas9-Mediated Genetic Intervention. Research Square DOI 10.21203/rs.3.rs-4193533/v1 YÖKSİS
  9. 2023 Bacterial Circadian Rhythm Turkish Society of Microbiology DOI 10.54453/TMCD.2023.04657 YÖKSİS TR Index OpenAlex 2.5%
  10. 2021 COVID-19 Pandemisinde Mikrobiyolojik Tanı Yöntemleri Turk Mikrobiyol Cemiy Derg DOI 10.5222/TMCD.2021.47550 YÖKSİS TR Index OpenAlex 8.4%
  11. 2021 Antimicrobial Activity Evaluation of Newly Synthesized N,N-Disubstituted Taurinamidobenzenesulfonamide Derivatives Journal of the Turkish Chemical Society, Section A: Chemistry DOI 10.18596/jotcsa.834579 YÖKSİS TR Index SJR Q4 OpenAlex 34.3%
  12. 2020 Antifungal and Antibiofilm Activities of SelectiveSerotonin Reuptake Inhibitors Alone and inCombination with Fluconazole Turkish Journal of Pharmaceutical Sciences DOI 10.4274/tjps.galenos.2019.65481 YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 65.3%
  13. 2020 Antifungal and antibiofilm activities of selective serotonin reuptake inhibitors alone and in combination with fluconazole Turkish Journal of Pharmaceutical Sciences DOI 10.4274/tjps.65481 YÖKSİS TR Index SJR Q3 JCR Q3 OpenAlex 16.3%
  14. 2011 Vertical Intra industry Trade and Fragmentation An Empirical Examination of the US Auto parts Industry World Economy DOI 10.1111/j.1467-9701.2010.01316.x YÖKSİS OpenAlex üst %10 OpenAlex 96.8%
  15. 2026 Comparison of Ion Release and Antibacterial Activity of Zinc-Containing and Conventional Glass Ionomer Cements Under Different pH Conditions: In Vitro Study Turkiye Klinikleri Journal of Dental Sciences DOI 10.5336/dentalsci.2025-112526 YÖKSİS OpenAlex 9.0%
  16. 2024 Antibacterial activity and cytocompatibility evaluation of cefpodoxime proxetil loaded eudragit rs 100 nanoparticles Journal of Research in Pharmacy DOI 10.29228/jrp.2022.00 YÖKSİS TR Index SJR Q3 JCR Q4
  17. 2023 DESIGN OF AZITHROMYCIN LOADED EUDRAGIT RL 100 NANOPARTICLES WITH EXTENDED ANTIBACTERIAL EFFECT Societatea de Stiinte Farmaceutice din Romania DOI 10.31925/farmacia.2023.2.15 YÖKSİS SJR Q2 JCR Q4 OpenAlex 79.5%
  18. 2021 Antimicrobial activity screening of a series of taurine derivatives Cumhuriyet Science Journal DOI 10.17776/csj.989570 YÖKSİS TR Index
  19. 2021 Microbiological Diagnostic Methods in COVID-19 Pandemic Türk Mikrobiyoloji Cemiyeti Dergisi DOI 10.5222/tmcd.2021.47550 YÖKSİS TR Index OpenAlex 8.4%
  20. 2020 Alternative Therapy to Antibiotics: CRISPR-Cas antimicrobials Gene Editing DOI 10.29228/genediting.41450 YÖKSİS OpenAlex 44.4%

Akademisyenlere dön